What's good for pharma is good for America
Critics of drug companies vastly overstate the industry's financial well-being -- and overlook its indispensable contributions to the future of public health
THE WINDS OF POLITICAL FORTUNE have brought the Democrats into power in both houses of Congress, and high on their 2007 agenda is tightening the regulatory screws on the pharmaceutical industry. It seems highly likely that the new Congress will seek to intervene on such hot-button issues as FDA oversight of drug safety, patent protection, and drug pricing. (Full article: 1741 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass
